Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients With Mild Hypoxemia
mediaposted on 07.05.2021, 15:09 by Adis journals on behalf of, Matthew Geriak, Fadi Haddad, Ravina Kullar, Kristina L. Greenwood, MacKenzie Habib, Cole Habib, David Willms, George Sakoulas
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.